Relief Cardiovascular recently announced that it closed a $12 million Series A round to help initiate a first-in-human feasibility study for its Relief System.
Chris Newmarker is the Executive Editor of Life Sciences. He covers a range of themes including medicine and healthcare, diagnostics, and business and economics, with a particular focus on the FDA, market trends, and influential business leaders in the healthcare sector. Chris is featured in prominent publications such as Drug Delivery Business News, Medical Design & Outsourcing, and MassDevice.